| Autor: |
Fang JX; Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA. Electronic address: fangjonathan@gmail.com., Villablanca PA; Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA., O'Neill BP; Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA., Wang DD; Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA., Engel Gonzalez P; Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA., Dali S; Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA., Giustino G; Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA., Lee JC; Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA., O'Neill WW; Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA., Frisoli TM; Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA. Electronic address: tfrisoli@gmail.com. |
| Abstrakt: |
Competing Interests: Funding Support and Author Disclosures Dr Villablanca is a consultant for Edwards Lifesciences and Teleflex. Dr B.P. O’Neill is a consultant for and has received research support from Edwards Lifesciences. Dr Wang is a consultant for Edwards Lifesciences, Abbott, and Boston Scientific. Dr Lee is a consultant for Edwards Lifesciences. Dr W. O’Neill has served as a consultant for Abiomed, Edwards Lifesciences, Medtronic, Boston Scientific, Abbott Vascular, and St. Jude Medical; and serves on the Board of Directors of Neovasc Inc. Dr Frisoli is a proctor for Edwards Lifesciences, Abbott, Boston Scientific, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. |
